The International Scleroderma Network thanks Genentech for their sponsorship support! Posted 12/21/2014.
The International Scleroderma Network thanks Gilead for their sponsorship support! Posted 12/14/2014.
Would you like to help scientists find a cure for scleroderma? Dozens of clinical trials for scleroderma and pulmonary hypertension are actively recruiting now. Review them and be sure to ask your scleroderma expert about the ones you are interested in. Posted 12/09/2014. (Also see Current Clinical Trials and Scleroderma Experts)
Did you know you can help raise scleroderma awareness? The nonprofit International Scleroderma Network offers scleroderma awareness bracelets! Bracelets for just $2.50 each with free shipping and handling! They say "scleroderma" on one side and "sclero.org" on the other. Posted 12/07/2014.
The International Scleroderma Network thanks United Therapeutics for their sponsorship support! Posted 12/06/2014.
Shop at AmazonSmile and Amazon will make a donation to the nonprofit International Scleroderma Network! Posted 12/04/2014.
The International Scleroderma Network thanks Shelley Ensz, Janet Paulmenn, and Sid and Sandy Strong, for their generous donations to tackle scleroderma in loving memory of Shelley's son, Nolan LaTourelle, who passed away suddenly on November 10th. Nolan was a co-founder of the ISN and is dearly missed by all. Posted 12/02/2014.
The International Scleroderma Network thanks Actelion Pharmaceuticals US, Inc. for their sponsorship support! Posted 12/02/2014.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email firstname.lastname@example.org to request our Welcome email, or to report bad links or to update this page content.